Biocides The Americas 2024

Moderator

• Overview of AD’s organizational structure, staffing updates, and scope of activities
• Highlight AD’s FY24 accomplishments
• Workload challenges, performance metrics, and process efficiencies
• Overview of AD’s FY25 priorities

• The overall schedule for Reg Review.
• Status of some of the larger cases, including quats and Its (isothiazolones)
• How is EPA coordinating with other offices within EPA with respect to ethylene oxide and any other actives which involve multiple program offices
• What is the status of the next round of reg review activities?  What compounds are being prioritized?
• How is EPA integrating ESA considerations into antimicrobial registration review decisions

• Current status
• Schedule
• Common takeaways from past registration review actions
• Next Steps
• ESA concerns
• ED concerns

• FIFRA Hot Topics
• Registration Issues
• Post-Election Analysis

• A brief overview of the Antimicrobials Division (AD) and the intersection of the different statutes that govern our work
• Discuss AD’s approach to address the Endangered Species Act (ESA), both for registration review and registration of new chemicals, and the challenges we face
• An update on the AD’s ESA efforts and what industry can do to help

• Comparison with conventional agricultural pesticides: differences in antimicrobial uses and chemistries
• Registrant challenges in providing relevant ESA information to EPA
• Opportunities for further collaboration and feedback

• COVID-19 and pesticide devices: EPA’s positioning
• Public health labeling claims 
• Substantiating product claims 
• Imported devices
• State regulation of devices

Moderator

• History of US EPA Emerging Viral Pathogen (EVP) guidance
• Creation of Pesticide Program Dialogue Committee (PPDC) Emerging Viral Pathogen Workgroup (EVPWG)
• Current PPDC Emerging Pathogen Implementation Committee (EPIC) structure and sunset
• Accomplishments and final recommendations to EPA from PPDC EPIC communication/education and policy sub-workgroups
• Update on the PPDC EPIC Technical Committee Efforts
• Proposed changes for EVP Policy
• Proposed policies for all other microbes
• Final recommendations

• Overview of EPA guidance and test method to support claims against planktonic Legionella pneumophila in cooling tower water
• Discussion of draft EPA guidance for addition of viral claims to sanitizer products
• EPA guidance documents/test methods anticipated in 2024 – 2025

• The impacts of other EPA programs on the regulation of antimicrobials by the US EPA
• How the TSCA program intersects with the FIFRA program
• Discussion of how hazard assessments conducted by other program offices in EPA, including the Office of Research and Development, the Office of Air and Radiation, and the TSCA program, can impact antimicrobial assessments conducted by the pesticides program
• Chemical examples used will include PFAS, Ethylene Oxide, and Formaldehyde

• Understanding the emergence of PFAS issues
• Regulatory landscape and EPA actions
• Current compliance requirements
• Best practices for registrants

• PRIA Coalition
• PRIA 5 Bilingual Labeling Requirements
• EPA Spanish Translation Guide
• Stakeholder and Engagement Outreach
• FAQs and considerations

• Overview of the data compensation provisions under FIFRA
• Complying with data compensation procedures
• Data compensation disputes
• Non-disclosure Agreements
• FIFRA data compensation arbitrations

• Current Status
• Implementation of key provisions
• Effect on cost of registration
• Revised active ingredient renewal process
• Next Steps
• What are registrants to do?